Literature DB >> 9427761

EDEN and EDEN-BP, a cis element and an associated factor that mediate sequence-specific mRNA deadenylation in Xenopus embryos.

L Paillard1, F Omilli, V Legagneux, T Bassez, D Maniey, H B Osborne.   

Abstract

During Xenopus early development, gene expression is regulated mainly at the translational level by the length of the poly(A) tail of mRNAs. The Eg family and c-mos maternal mRNAs are deadenylated rapidly and translationally repressed after fertilization. Here, we characterize a short sequence element (EDEN) responsible for the rapid deadenylation of Eg5 mRNA. Determining the core EDEN sequence permitted us to localize the c-mos EDEN sequence. The c-mos EDEN confered a rapid deadenylation to a reporter gene. The EDEN-specific RNA-binding protein (EDEN-BP) was purified and a cDNA obtained. EDEN-BP is highly homologous to a human protein possibly involved in myotonic dystrophy. Immunodepleting EDEN-BP from an egg extract totally abolished the EDEN-mediated deadenylation activity, but did not affect the default deadenylation activity. Therefore, EDEN-BP constitutes the first trans-acting factor for which an essential role in the specificity of mRNA deadenylation has been directly demonstrated.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9427761      PMCID: PMC1170378          DOI: 10.1093/emboj/17.1.278

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  42 in total

1.  Peptide production from proteins separated by sodium dodecyl-sulfate polyacrylamide gel electrophoresis.

Authors:  C E Prussak; M T Almazan; B Y Tseng
Journal:  Anal Biochem       Date:  1989-05-01       Impact factor: 3.365

2.  Changes in the polyadenylation of specific stable RNA during the early development of Xenopus laevis.

Authors:  J Paris; H B Osborne; A Couturier; R Le Guellec; M Philippe
Journal:  Gene       Date:  1988-12-10       Impact factor: 3.688

3.  Functional messenger RNAs are produced by SP6 in vitro transcription of cloned cDNAs.

Authors:  P A Krieg; D A Melton
Journal:  Nucleic Acids Res       Date:  1984-09-25       Impact factor: 16.971

4.  Rapid and efficient site-specific mutagenesis without phenotypic selection.

Authors:  T A Kunkel
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

5.  The poly(A) binding protein is required for poly(A) shortening and 60S ribosomal subunit-dependent translation initiation.

Authors:  A B Sachs; R W Davis
Journal:  Cell       Date:  1989-09-08       Impact factor: 41.582

6.  The c-mos proto-oncogene product is a cytostatic factor responsible for meiotic arrest in vertebrate eggs.

Authors:  N Sagata; N Watanabe; G F Vande Woude; Y Ikawa
Journal:  Nature       Date:  1989-11-30       Impact factor: 49.962

7.  Poly(A) elongation during Xenopus oocyte maturation is required for translational recruitment and is mediated by a short sequence element.

Authors:  L L McGrew; E Dworkin-Rastl; M B Dworkin; J D Richter
Journal:  Genes Dev       Date:  1989-06       Impact factor: 11.361

8.  Primary structures of the heterogeneous nuclear ribonucleoprotein A2, B1, and C2 proteins: a diversity of RNA binding proteins is generated by small peptide inserts.

Authors:  C G Burd; M S Swanson; M Görlach; G Dreyfuss
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

9.  Function of c-mos proto-oncogene product in meiotic maturation in Xenopus oocytes.

Authors:  N Sagata; M Oskarsson; T Copeland; J Brumbaugh; G F Vande Woude
Journal:  Nature       Date:  1988-10-06       Impact factor: 49.962

10.  Stability of RNA in developing Xenopus embryos and identification of a destabilizing sequence in TFIIIA messenger RNA.

Authors:  R Harland; L Misher
Journal:  Development       Date:  1988-04       Impact factor: 6.868

View more
  66 in total

1.  Zygotic regulation of maternal cyclin A1 and B2 mRNAs.

Authors:  Y Audic; C Anderson; R Bhatty; R S Hartley
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

2.  Cytoplasmic polyadenylation elements mediate masking and unmasking of cyclin B1 mRNA.

Authors:  C H de Moor; J D Richter
Journal:  EMBO J       Date:  1999-04-15       Impact factor: 11.598

3.  EDEN-dependent translational repression of maternal mRNAs is conserved between Xenopus and Drosophila.

Authors:  Nader Ezzeddine; Luc Paillard; Michele Capri; Dominique Maniey; Therese Bassez; Ounissa Ait-Ahmed; H Beverley Osborne
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-26       Impact factor: 11.205

Review 4.  Cytoplasmic polyadenylation in development and beyond.

Authors:  J D Richter
Journal:  Microbiol Mol Biol Rev       Date:  1999-06       Impact factor: 11.056

Review 5.  To polyadenylate or to deadenylate: that is the question.

Authors:  Xiaokan Zhang; Anders Virtanen; Frida E Kleiman
Journal:  Cell Cycle       Date:  2010-11-15       Impact factor: 4.534

Review 6.  Diverse regulation of 3' splice site usage.

Authors:  Muhammad Sohail; Jiuyong Xie
Journal:  Cell Mol Life Sci       Date:  2015-09-14       Impact factor: 9.261

Review 7.  Zygotic genome activation during the maternal-to-zygotic transition.

Authors:  Miler T Lee; Ashley R Bonneau; Antonio J Giraldez
Journal:  Annu Rev Cell Dev Biol       Date:  2014-08-11       Impact factor: 13.827

8.  Identification and characterization of two novel classes of small RNAs in the mouse germline: retrotransposon-derived siRNAs in oocytes and germline small RNAs in testes.

Authors:  Toshiaki Watanabe; Atsushi Takeda; Tomoyuki Tsukiyama; Kazuyuki Mise; Tetsuro Okuno; Hiroyuki Sasaki; Naojiro Minami; Hiroshi Imai
Journal:  Genes Dev       Date:  2006-06-09       Impact factor: 11.361

Review 9.  Coordinate regulation of mRNA decay networks by GU-rich elements and CELF1.

Authors:  Irina Vlasova-St Louis; Paul R Bohjanen
Journal:  Curr Opin Genet Dev       Date:  2011-04-13       Impact factor: 5.578

Review 10.  CELFish ways to modulate mRNA decay.

Authors:  Irina Vlasova-St Louis; Alexa M Dickson; Paul R Bohjanen; Carol J Wilusz
Journal:  Biochim Biophys Acta       Date:  2013-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.